Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.40
- Piotroski Score 4.00
- Grade N/A
- Symbol (STAB)
- Company Statera Biopharma, Inc.
- Price $0.00
- Changes Percentage (100%)
- Change -$0
- Day Low $0.00
- Day High $0.00
- Year High $0.04
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.36
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $-174,408,164
Income Statement
Quarterly
Annual
Latest News of STAB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Franklin Resources, Inc. (BEN): Leveraging Strategic Acquisitions for Growth and Stability
The article discusses the importance of dividend investing and highlights Franklin Resources, Inc. as a Dividend Achiever with consistent dividend growth. BEN offers a quarterly dividend of $0.31 per ...
By Yahoo! Finance | 10 hours ago -
49ers use game against Patriots to stabilize after back-to-back losses
The San Francisco 49ers defeated the New England Patriots 30-13, showcasing big plays from Warner, Purdy, Kittle, and the defense. Despite some mistakes, they aim to improve for tougher matchups ahead...
By CBS News | 12 hours ago -
A Texas man is set to be executed for fatally stabbing twin teenage girls in 1989
61-year-old Garcia White, linked to five murders including the fatal stabbing of twin 16-year-old girls in 1989, is set to be executed in Texas. White's lawyers have sought to stop the execution citin...
By AP NEWS | 14 hours ago